Intellia Therapeutics Inc buy Royal Bank of Canada
Start price
08.08.25
/
50%
€9.24
Target price
08.08.26
€18.01
Performance (%)
13.47%
End price
09.08.26
€10.48
Summary
This prediction ended on 09.08.26 with a price of €10.48. The BUY prediction by Royal_Bank_of_Canada finished with a performance of 13.47%. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 4.102% | 4.102% | 21.717% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Royal Bank Of Canada from $25.00 to $21.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Royal_Bank_of_Canada for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€20.95
19.09.24
19.09.24
€48.55
19.09.25
19.09.25
-35.54%
20.09.25
20.09.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€19.65
09.08.24
09.08.24
€49.44
09.08.25
09.08.25
-52.65%
10.08.25
10.08.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€65.49
10.11.24
10.11.24
-30.16%
11.11.24
11.11.24